Volume 9, Number 7—July 2003
Dispatch
VIM- and IMP-Type Metallo-β-lactamase–Producing Pseudomonas spp. and Acinetobacter spp. in Korean Hospitals
Kyungwon Lee*, Wee Gyo Lee†, Young Uh‡, Gyoung Yim Ha§, Jihyun Cho¶, Yunsop Chong*
, and the Korean Nationwide Surveillance of Antimicrobial Resistance group1
, and the Korean Nationwide Surveillance of Antimicrobial Resistance group1
Table 3
blaVIM-2 and blaIMP-1 allele-positive Pseudomonas spp. and Acinetobacter spp. isolated by service
| Organism | No. isolates (%) |
||||
|---|---|---|---|---|---|
| Outpatient | Inpatient | Intensive-care unit | Others | Total | |
| Pseudomonas spp. |
3 (6.8)a |
26 (59.1) |
11 (25.0) |
4 (9.1) |
44 (100) |
| Acinetobacter spp. |
2 (5.2)b |
15 (39.5) |
15 (39.5) |
6 (15.8) |
38 (100) |
| Total | 5 (6.1) | 41 (50.0) | 26 (31.7) | 10 (12.2) | 82 (100) |
aTwo were emergency service patients, and one was a urology patient.
bOne was an emergency service patient, and one was a pediatric patient.
1In addition to the listed authors, this group includes the following: Jung Oak Kang, Moon Yeon Kim, Nam Yong Lee, Mi-Na Kim, Myungshin Kim, Kyung Soon Song, Ki Sook Hong, In Ki Paik, Hye Soo Lee, Sook-Jin Jang, Ae Ja Park, Sung Ha Kang, Won Keun Song, Insoo Rheem, Eui-Chong Kim, Yeon Joon Park, Jong Hee Shin, Myungseo Kang, Young-Kyu Sun, Hee Joo Lee, Hwan-Sub Lim, Jong Wook Lee, and Bo-Moon Shin.
Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.